Cardiac strain is lower among women with HIV in relation to monocyte activation
Mabel Toribio(Boston College), Markella V. Zanni(Harvard University), Melissa Wang(Harvard University), Takara L. Stanley(Brigham and Women's Hospital), Thiago Quinaglia(Cardiovascular Research Center), Magid Awadalla(Massachusetts General Hospital), David A. Alagpulinsa(Harvard University), Giselle Alexandra Suero‐Abreu(Massachusetts General Hospital), Zsófia D. Drobni(Semmelweis University), Michael D. Nelson(The University of Texas at Arlington), Claudia G. Durbin(Harvard University), Tricia H. Burdo(Temple University), Tomas G. Neilan(Albert Einstein College of Medicine), Christopher T. Longenecker(Case Western Reserve University), Lindsay T. Fourman(Massachusetts General Hospital)
Cited by 2
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
|Clinical Infectious Diseases|2001|680
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589